Maravai LifeSciences Holdings, Inc. (MRVI) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Maravai LifeSciences (MRVI) Q1 2026: EBITDA Guidance Raised 63% on GMP Mix Shift
May 08, 2026
-
Maravai LifeSciences (MRVI) Q4 2025: $65M Cost Cuts Reset Margin Structure, TriLink Base Revenue Up 25%
February 26, 2026
-
Maravai (MRVI) Q2 2025: $50M Cost Reset Targets 2026 Profitability as BST Grows 10%
August 12, 2025
-
Maravai Life Sciences (MRVI) Q1 2025: BST Delivers 70% Margin as NAP Base Builds Post-COVID
July 07, 2025